Tau is associated with the amyloid beta plaques and tau tangles that riddle the brains of people with Alzheimer’s, ...

A computer program predicts with more than 75% accuracy who will develop dementia in the near future. D.C. residents drive ...

A supplement already taken by thousands and costing less than 10p a pill on the high street could help protect women against ...

Longer-term data show that donanemab’s cognitive benefits continue to grow over time, and earlier initiation reduces the risk for progression, with no new safety signals.

Medicare launched a new program called GUIDE (Guiding an Improved Dementia Experience) to support individuals diagnosed with ...

Disease-modifying therapies are expected to account for 69.2% of the market. The Alzheimer’s disease (AD) market across the ...

A year after earning FDA approval for Kisunla, Eli Lilly is shining a light on the anti-amyloid Alzheimer’s disease therapy ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

Seniors experiencing memory problems and cognitive decline now have access to a new diagnostic blood test to detect Alzheimer’s disease. Labcorp this week unveiled the first Food and Drug ...

The concept of vagus nerve stimulation dates back to the late 19th century, when a stimulator to treat epileptic patients was ...

BAKU – Scientists have identified two natural compounds that show promise in reversing brain cell ageing and removing harmful protein buildup, potentially offering a non-drug approach for Alzheimer’s ...